跳至主要内容
临床试验/NCT02986087
NCT02986087招募中不适用

Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia

Children's Hospital Medical Center, Cincinnati2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年11月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Change lung growth on prenatal imaging

研究概览

简要总结

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses.

详细描述

Fetuses with congenital diaphragmatic hernia with liver-up, and an observed to expected lung-to-head ratio of <25%, LHR <1, or a moderate category with o/e LHR <30%, singleton pregnancy, no known other anomalies, gestational age < 29 weeks 6 days (severe), gestational age < 31 weeks 6 days (moderate), no maternal disease, maternal age > 18 years old.... meet criteria to be offered fetal tracheal occlusion. We want to test feasibility and efficacy in our center.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Isolated CDH with liver up
  • Severe pulmonary hypoplasia with ultrasound O/E LHR <25% at the time of surgery
  • Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days
  • Moderate pulmonary hypoplasia with ultrasound O/E LHR <30% and liver-up at the time of surgery
  • Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category
  • Maternal age greater than or equal to 18 years
  • Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category
  • Normal karyotype or FISH
  • Normal fetal echocardiogram
  • Singleton pregnancy
  • Willing to remain in the greater Cincinnati area for remainder of pregnancy
  • Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days
  • Family meets psychosocial criteria

排除标准

  • Patient < 18 years old
  • Multi-fetal pregnancy
  • Rubber latex allergy
  • Preterm labor, cervix shortened (<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa
  • Bilateral CDH, isolated left sided CDH with an O/E > 30%
  • Additional fetal anomaly by ultrasound, MRI, or echocardiogram
  • Chromosomal abnormalities
  • Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy
  • Incompetent cervix with or without a cerclage
  • Placental abnormalities known at time of enrollment
  • Maternal HIV, Hepatits B, Hepatitis C
  • Maternal uterine anomaly
  • No safe or technically feasible fetoscopic approach to balloon placement
  • Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy

结局指标

主要结局

Change lung growth on prenatal imaging

时间窗: prenatal period up to 40 weeks gestation

Change in o/eLHR and other prenatal imaging tests

次要结局

  • Change need for ECMO therapy(6 months)
  • Change neonatal morbidity(1 year)
  • Change survival in the severe congenital diaphragmatic hernia subgroup(6 months)
  • Change pulmonary hypertension(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验